0.00Open4.10Pre Close0 Volume10 Open Interest20.00Strike Price0.00Turnover57.12%IV12.30%PremiumDec 20, 2024Expiry Date1.87Intrinsic Value100Multiplier16DDays to Expiry2.23Extrinsic Value100Contract SizeAmericanOptions Type-0.7821Delta0.1390Gamma8.34Leverage Ratio-0.0184Theta-0.0057Rho-6.52Eff Leverage0.0111Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet